vimarsana.com

Latest Breaking News On - Larry heaton - Page 5 : vimarsana.com

Zomedica Corp (AMEX:ZOM) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Zomedica s Fourth Quarter and Full-Year 2023 Earnings Release and Business Update Call.

San diegoUnited statesNew hampshirePeter donatoObiata caderiShane wilsonWood chuckElif mcdonaldLarry heatonZomedica universityAmerican stock exchangeStock exchangeUnidentified company representativeZomedica corpQorvo biotechnologiesYork stock exchange american

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100 5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United statesAnn arborLarry heatonMonitoring products incZomedica corpCompany global manufacturing distribution centers in roswellQorvo biotechnologiesTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Ful

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the four.

United statesAnn arborLarry heatonMonitoring products incQorvo biotechnologiesCompany global manufacturing distribution centers in roswellZomedica corpTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter .

United statesLarry heatonCompany global manufacturing distribution centers in roswellNews networkMonitoring products incZomedica corpQorvo biotechnologiesTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100 5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United statesAnn arborLarry heatonMonitoring products incCompany global manufacturing distribution centers in roswellQorvo biotechnologiesZomedica corpTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

vimarsana © 2020. All Rights Reserved.